55
Views
7
CrossRef citations to date
0
Altmetric
DEBATING DRUGS

The history of the ‘drugs problem’

Pages 3-5 | Published online: 13 Mar 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kojo Koram. (2022) Phantasmal commodities: law, violence and the juris-diction of drugs. Third World Quarterly 43:11, pages 2731-2746.
Read now
Sasha Breger Bush & Matthew Kriese. (2020) Rethinking drugs. Review of Social Economy 78:4, pages 479-506.
Read now

Articles from other publishers (5)

Sonia Soans. (2023) Inebriation and death of women: Making sense of women’s alcohol and drug consumption in Bollywood and society. Psychology of Women and Equalities Section Review 6:1, pages 32-42.
Crossref
Axel Klein & Blaine Stothard. 2018. Collapse of the Global Order on Drugs: From UNGASS 2016 to Review 2019. Collapse of the Global Order on Drugs: From UNGASS 2016 to Review 2019 1 19 .
Melissa Bone, Gary Potter & Axel Klein. (2018) Introduction: cultivation, medication, activism and cannabis policy. Drugs and Alcohol Today 18:2, pages 73-79.
Crossref
Axel Klein. (2013) The Khat ban in the UK: What about the ‘scientific’ evidence? (Respond to this article at http://www.therai.org.uk/at/debate). Anthropology Today 29:5, pages 6-8.
Crossref
Toby Seddon. (2010) Let's not talk about drugs. Drugs and Alcohol Today 10:3, pages 21-23.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.